May 26, 2021

BioLineRx Reports First Quarter 2021 Financial Results and Provides Corporate Update

May 20, 2021

BioLineRx to Report First Quarter 2021 Results on May 26, 2021

May 4, 2021

BioLineRx Announces Positive Top-Line Results from GENESIS Phase 3 Trial of Motixafortide in Stem-Cell Mobilization for Autologous Bone Marrow Transplantation in Multiple Myeloma Patients